Breckenridge Pharmaceutical, Inc. Recalls

2 recalls found for Breckenridge Pharmaceutical, Inc.. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Breckenridge Recalls Duloxetine Capsules Over Chemical Hazard

Breckenridge Pharmaceutical, Inc. recalled 7,389 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations and the presence of N-nitroso-duloxetine impurity above FDA limits. Consumers should stop using the product immediately and contact healthcare providers for guidance.

DULOXETINE
CGMP Deviations;
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

DULOXETINE